Enterin, Inc.

Biotechnology company · Philadelphia, Pennsylvania, United States

Enterin, Inc. is a biotechnology company headquartered in Philadelphia, Pennsylvania, United States. Its earliest recorded incorporation is in 2014. It has reported private securities offerings to the US SEC, most recently $5.1 million sold in a notice filed in 2023.

Profile compiled from public records. Is this your company? Request a correction or update

Enterin at a glance

Typebiotechnology company

HeadquartersPhiladelphia, Pennsylvania, United States

Earliest incorporation on record2014

SEC industryBiological Products, (No Diagnostic Substances)

SEC CIK1711351

What does Enterin do?

Private fundraising reported to the SEC

6 Form D notices; the most recent reported $5.1 million sold (2023).

Frequently asked questions about Enterin

Where is Enterin headquartered?

Enterin, Inc. is headquartered in Philadelphia, Pennsylvania, United States.

What does Enterin do?

Enterin, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).

When was Enterin founded?

The earliest incorporation on record for Enterin, Inc. is in 2014, according to public company registers.

Similar companies

Spark Therapeutics, Inc.Philadelphia, Pennsylvania, United States
Cabaletta Bio, Inc.Philadelphia, Pennsylvania, United States
Passage BIO, Inc.Philadelphia, Pennsylvania, United States
ZSX Medical, LLCPhiladelphia, Pennsylvania, United States
Century Therapeutics, Inc.Philadelphia, Pennsylvania, United States
PolyCore Therapeutics, Inc.Philadelphia, Pennsylvania, United States
Five Eleven Pharma Inc.Philadelphia, Pennsylvania, United States
Trevarx Biomedical, Inc.Philadelphia, Pennsylvania, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences